[HTML][HTML] Levels of SARS-CoV-2 antibodies among fully vaccinated individuals with Delta or Omicron variant breakthrough infections
NB Stærke, J Reekie, H Nielsen, T Benfield… - Nature …, 2022 - nature.com
SARS-CoV-2 variants of concern have continuously evolved and may erode vaccine
induced immunity. In this observational cohort study, we determine the risk of breakthrough …
induced immunity. In this observational cohort study, we determine the risk of breakthrough …
[HTML][HTML] Time trends in per-and polyfluoroalkyl substances (PFAS) concentrations in the Danish population: A review based on published and newly analyzed data
SD Hull, L Deen, KU Petersen, TK Jensen… - Environmental …, 2023 - Elsevier
Introduction Per-and polyfluoroalkyl substances (PFAS) are persistent chemicals used in
many industries and everyday consumer products and exposure has been linked to several …
many industries and everyday consumer products and exposure has been linked to several …
Epidemiological and clinical characteristics of vaccinated COVID-19 patients: A meta-analysis and systematic review
W Tian, X Ren, M Han, Y Zhang… - International …, 2022 - journals.sagepub.com
Objective: With the global epidemic of coronavirus disease 2019 (COVID-19), vaccination
rates are increasing globally. This study evaluated the relevant clinical manifestations of …
rates are increasing globally. This study evaluated the relevant clinical manifestations of …
[HTML][HTML] Impact of age and comorbidities on SARS-CoV-2 vaccine-induced T cell immunity
LL Dietz, AK Juhl, OS Søgaard, J Reekie… - Communications …, 2023 - nature.com
Background Older age and chronic disease are important risk factors for developing severe
COVID-19. At population level, vaccine-induced immunity substantially reduces the risk of …
COVID-19. At population level, vaccine-induced immunity substantially reduces the risk of …
[HTML][HTML] Comparison of vaccine-induced antibody neutralization against SARS-CoV-2 variants of concern following primary and booster doses of COVID-19 vaccines
AK Hvidt, EAM Baerends, OS Søgaard… - Frontiers in …, 2022 - frontiersin.org
The SARS-CoV-2 pandemic has, as of July 2022, infected more than 550 million people and
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …
caused over 6 million deaths across the world. COVID-19 vaccines were quickly developed …
[HTML][HTML] COVID-19 vaccine immunogenicity in people with HIV
CT Costiniuk, J Singer, T Lee, MA Langlois, C Arnold… - Aids, 2023 - journals.lww.com
COVID-19 vaccine immunogenicity in people with HIV : AIDS COVID-19 vaccine immunogenicity
in people with HIV : AIDS Log in or Register Subscribe to journalSubscribe Get new issue …
in people with HIV : AIDS Log in or Register Subscribe to journalSubscribe Get new issue …
[HTML][HTML] Effect of vaccine booster, vaccine type, and hybrid immunity on humoral and cellular immunity against SARS-CoV-2 ancestral strain and Omicron variant …
CHY Fong, X Zhang, LL Chen, RWS Poon… - …, 2023 - thelancet.com
Background Vaccination reduces COVID-19-related hospitalization among older adults.
However, how SARS-CoV-2 infection and vaccine regimens affect vaccine-elicited immunity …
However, how SARS-CoV-2 infection and vaccine regimens affect vaccine-elicited immunity …
Omicron variant-specific serological imprinting following BA. 1 or BA. 4/5 bivalent vaccination and previous SARS-CoV-2 infection: A cohort study
EAM Baerends, J Reekie, SR Andreasen… - Clinical Infectious …, 2023 - academic.oup.com
Background Continuous evolution of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) outpaces monovalent vaccine cross-protection to new viral variants …
(SARS-CoV-2) outpaces monovalent vaccine cross-protection to new viral variants …
[HTML][HTML] Impact of comorbidities on the serological response to COVID-19 vaccination in a Taiwanese cohort
Abstract Background/Aims Vaccination against severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is one of the best policies to control COVID-19 pandemic. The …
coronavirus 2 (SARS-CoV-2) is one of the best policies to control COVID-19 pandemic. The …
[HTML][HTML] Long-term humoral and cellular immunity after primary SARS-CoV-2 infection: A 20-month longitudinal study
AK Hvidt, H Guo, R Andersen, SSF Lende, LK Vibholm… - BMC immunology, 2023 - Springer
Background SARS-CoV-2 remains a world-wide health issue. SARS-CoV-2-specific
immunity is induced upon both infection and vaccination. However, defining the long-term …
immunity is induced upon both infection and vaccination. However, defining the long-term …